Insulet price target raised to $310 from $300 at BTIG
BTIG raised the firm’s price target on Insulet (PODD) to $310 from $300 and keeps a Buy rating on the shares after its Q4 earnings beat. The ...
BTIG upgrades Snowflake to 'buy' on improving demand
BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth.
Nasdaq2mon
BTIG Initiates Coverage of ImmunityBio (IBRX) with Buy Recommendation
As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...
iRhythm price target raised to $135 from $120 at BTIG
BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...
Morningstar19d
BTIG to Host Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 11 - 12, 2025
For more information about the conference, email uscorporateaccess@btig.com. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG ...
Volatility watch: Wingstop earnings could lead to a big share price swing
BTIG highlights Wingstop (WING) as a top pick ahead of earnings, citing strong unit growth, supply chain benefits, & robust ...
Yahoo Finance26d
Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 28, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual ...
BTIG Sticks to Its Buy Rating for Zealand Pharma (ZLDPF)
In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...